knowledge -WSS

knowledge

author：hotspot 2025-09-30 00:10:07 - browse：632

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： N.Y. state detects polio case, first in the U.S. since 2013

explore

leisure time

WSS

Palantir health business leans on meeting customers’ needs

Medicaid, Medicare dual

NIH fellows want a pay raise. Will that mean less money for grants?

Retired US general questions alleged Putin, Prigozhin meeting

Oak trusses raised to roof of fire

Medicaid, Medicare dual

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Drug repurposing or repositioning? The language matters

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Medical leaders decry Supreme Court decision on affirmative action

Study: Pain burden is higher in Black NFL players than white ones

In Memoriam: Notable people who died in 2023

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Guidelines to prevent youth baseball injuries need more muscle

Paxlovid should be available without a positive Covid test

Apple is now the first public company to be valued at $3 trillion

Biden launches a new push to limit health care costs

hotspot

Data show record exodus of life scientists from academia

Why do women spend more than men on medical expenses?

Medicare drug price negotiation program allowed for now

Why do women spend more than men on medical expenses?

Shingles, which affected Dianne Feinstein, is on the rise

Address the ethical violations that led to 'Three Identical Strangers'

hotspot

explore

leisure time

explore